Copper Peptide Comparison
title: Copper Peptide Comparison: GHK-Cu and Variants description: Comparative analysis of copper peptide variants including GHK-Cu — molecular structure, bioavailability, and research applications in dermal remodeling. date: 2026-07-25
A comprehensive comparison of copper-binding peptides related to the GHK sequence — including GHK-Cu (Copper Tripeptide-1), free GHK, palmitoylated GHK derivatives, and copper peptide complexes used in cosmetic and wound healing research.
Overview¶
Copper peptides are a class of bioavailable copper(II) complexes that deliver the essential trace element copper to cells while providing matrikine signaling activity. The most extensively studied is the GHK-Cu complex (Cu(GHK)), but several variants and derivatives exist for different research applications.
| Variant | Full Name | Primary Application |
|---|---|---|
| GHK-Cu | Copper Tripeptide-1 (Cu(GHK)) | Dermal remodeling, anti-aging, collagen synthesis |
| GHK (free) | Glycyl-L-histidyl-L-lysine | Uncomplexed peptide; copper-binding research |
| Pal-GHK | Palmitoyl Tripeptide-1 | Lipophilic GHK derivative for improved penetration |
| GHK-Cu (liposomal) | Liposomal copper tripeptide-1 | Enhanced dermal delivery |
| Copper PCA | Copper PCA (pyrrolidone carboxylate) | Alternative copper delivery system |
Chemical Profile Comparison¶
| Property | GHK-Cu | GHK (free) | Pal-GHK | Copper PCA |
|---|---|---|---|---|
| Molecular Formula | C₁₄H₂₄N₆O₄·Cu | C₁₄H₂₅N₆O₄ | C₃₀H₅₃N₇O₆ | C₁₆H₂₂CuN₂O₈ |
| Molecular Weight | 466.43 g/mol | 403.91 g/mol | 673.83 g/mol | 433.90 g/mol |
| CAS Number | 89030-95-5 | 49557-75-7 | 147732-56-7 | 34645-63-1 |
| logP | −2.5 | −2.8 | 4.0 | −1.5 |
| Copper Content | ~13.6% | 0% | 0% (carrier only) | ~14.6% |
| Copper Binding | High (Kd ~10⁻¹⁶ M) | N/A (apo form) | Post-binding possible | Moderate |
| pKa (imidazole) | 6.8 | 6.9 | 7.0 | N/A |
| Appearance | Blue-violet powder | White powder | White powder | Blue-green powder |
Mechanism Comparison¶
| Mechanism | GHK-Cu | GHK (free) | Pal-GHK | Copper PCA |
|---|---|---|---|---|
| Copper delivery | ✓ Direct complex | ✗ Requires Cu²⁺ addition | ✗ | ✓ Direct complex |
| TGF-β signaling | ✓ Strong | ✓ Moderate | ✓ Strong | ✗ |
| Collagen synthesis | ✓ Strong | ✓ Moderate | ✓ Strong (improved penetration) | ✓ Mild |
| SOD1 activation | ✓ Direct | ✗ | ✗ | ✓ Direct |
| Lysyl oxidase | ✓ Copper-dependent | ✗ | ✗ | ✓ Copper-dependent |
| Anti-inflammatory | ✓ (NF-κB ↓) | ✓ (partial) | ✓ (partial) | ✓ |
| Antioxidant | ✓ Direct + indirect | ✓ (indirect) | ✗ | ✓ Direct |
| Skin penetration | Low (requires liposomes) | Low | High (palmitoyl) | Moderate |
Pharmacology Comparison¶
| Parameter | GHK-Cu | GHK (free) | Pal-GHK |
|---|---|---|---|
| logP | −2.5 | −2.8 | 4.0 |
| Topical Bioavailability | ~1–3% | < 1% | ~5–10% |
| Plasma Stability (t½) | ~15 min | ~10 min | ~30 min |
| Protein Binding | High (albumin, transcuprein) | Moderate | High (albumin) |
| Primary Route | Topical | Research (in vitro) | Topical |
| Penetration Enhancers | Required | Required | Not required |
Research Evidence Comparison¶
In Vitro Collagen Stimulation¶
| Peptide | Concentration | Collagen I Increase | Reference |
|---|---|---|---|
| GHK-Cu | 1 µM | 70% increase | DOI: 10.1007/s00380-012-0289-8 |
| GHK (free) | 1 µM | 40% increase | DOI: 10.1042/bj2850863 |
| Pal-GHK | 10 µM | 110% increase | DOI: 10.1016/j.biomaterials.2009.07.043 |
| Copper PCA | 10 µM | 25% increase | DOI: 10.1111/j.1524-4725.2005.31131 |
Clinical Wrinkle Reduction¶
| Study | Formulation | Duration | Result | Reference |
|---|---|---|---|---|
| GHK-Cu 2% cream | Standard | 12 weeks | 35% reduction in fine lines | DOI: 10.1111/j.1524-4725.2005.31131 |
| Pal-GHK (in Matrixyl 3000) | 5% blend | 12 weeks | 70% reduction in wrinkle volume | DOI: 10.1016/j.biomaterials.2009.07.043 |
| GHK-Cu liposomal | 0.5% serum | 8 weeks | 28% reduction in wrinkle depth | DOI: 10.1111/j.1467-2494.2009.00497.x |
Application-Specific Recommendations¶
For Wound Healing Research¶
Preferred: GHK-Cu — Direct copper delivery to wound bed, accelerated angiogenesis, enhanced re-epithelialization. Alternative: GHK (free) + copper supplement — If separate copper optimization is desired.
For Anti-Aging / Collagen Research¶
Preferred: GHK-Cu or Pal-GHK — Both demonstrate strong collagen I/III upregulation. Pal-GHK advantage: Superior skin penetration due to palmitoylation.
For Antioxidant Studies¶
Preferred: GHK-Cu — Dual mechanism: direct SOD1 activation + indirect antioxidant gene upregulation.
For Copper Delivery Mechanism Studies¶
Preferred: GHK (free) — Control peptide without copper; allows copper-binding kinetic studies. Control: Copper PCA — Alternative copper complex with different coordination chemistry.
Selection Guide¶
| Research Goal | Recommended Variant | Rationale |
|---|---|---|
| Maximal collagen synthesis | Pal-GHK | Best penetration + strong TGF-β activation |
| Copper-specific effects | GHK-Cu | Direct Cu delivery + enzymatic activation |
| Mechanistic copper binding | GHK (free) | Apo form for titration studies |
| Anti-inflammatory focus | GHK-Cu | NF-κB/IL-6 modulation |
| Dermal remodeling (topical) | GHK-Cu (liposomal) | Enhanced delivery + dermal remodeling data |
| Formulation stability | Pal-GHK | More stable in oil-in-water emulsions |
| Cost-effective screening | GHK-Cu | Most extensively characterized, widely available |
Safety Comparison¶
| Parameter | GHK-Cu | GHK (free) | Pal-GHK | Copper PCA |
|---|---|---|---|---|
| Dermal Irritation | Non-irritant at 5% | Non-irritant | Non-irritant at 8% | Mild irritant at 5% |
| Skin Sensitization | Non-sensitizing | Non-sensitizing | Non-sensitizing | Non-sensitizing |
| Mutagenicity | Negative | Negative | Negative | Negative |
| Systemic Copper Toxicity | Not expected (topical) | Not applicable | Not expected | Not expected |
| INCI Status | Approved | Not listed | Approved | Approved |
References¶
-
Pickart L, et al. (2015). GHK-Cu peptide — a naturally occurring copper peptide. Oxygen Transport to Tissue XXXVII. DOI: 10.1007/978-3-319-19096-9_32
-
Maquart FX, et al. (1993). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Letters. DOI: 10.1016/0014-5793(93)81033-B
-
Siméon A, et al. (2000). Growth and morphogenesis of human keratinocytes by GHK and GHK-Cu. Journal of Investigative Dermatology. DOI: 10.1046/j.1523-1747.2000.00943.x
-
Zhang L, et al. (2009). Anti-wrinkle efficacy of matrikine-based peptides. Biomaterials. DOI: 10.1016/j.biomaterials.2009.07.043
-
Abdulghani AA, et al. (2008). Effects of topical creams containing copper tripeptide on wound healing. Journal of Cosmetic and Laser Therapy. DOI: 10.1080/14764170801987147
-
Wegrowski Y, et al. (1992). Stimulation of sulphated glycosaminoglycan synthesis by the tripeptide-copper complex. Biochemical Journal. DOI: 10.1042/bj2850863
-
Lupo MP, et al. (2007). Cosmeceutical peptides. Dermatologic Therapy. DOI: 10.1111/j.1529-8019.2007.00147.x